The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is it time to change the primary endpoint in clinical trials in recurrent ovarian cancer (ROC)?: Symptom burden and outcomes in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive ROC receiving ≥ 3 lines of chemotherapy (PPS ≥ 3)—The Gynecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS).
 
Michael Friedlander
Honoraria - Clovis Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche
Research Funding - AstraZeneca (Inst)
 
Martin R. Stockler
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bionomics (Inst); Celgene (Inst); Medivation (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Rachel O'Connell
No Relationships to Disclose
 
Florence Joly
No Relationships to Disclose
 
Anne Lanceley
No Relationships to Disclose
 
Felix Hilpert
Honoraria - Amgen; AstraZeneca; MSD; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; MSD; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Roche Pharma AG
 
Aikou Okamoto
No Relationships to Disclose
 
Eriko Aotani
No Relationships to Disclose
 
Sandro Pignata
Honoraria - AstraZeneca; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Research Funding - AstraZeneca; Janssen; Roche Pharma AG
 
Paul P. Donnellan
No Relationships to Disclose
 
Amit M. Oza
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Elisabeth Avall-Lundqvist
Honoraria - Boehringer Ingelheim; MSD; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca
 
Jonathan S. Berek
Consulting or Advisory Role - Atara Biotherapeutics; Prima BioMed
Research Funding - AstraZeneca (Inst); Endocyte (Inst); Genentech (Inst); Merck (Inst); Prima BioMed (Inst); Quest Diagnostics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Prima BioMed
 
Katrin Marie Sjoquist
Travel, Accommodations, Expenses - Merck Serono
 
Kim Gillies
No Relationships to Disclose
 
Phyllis Butow
No Relationships to Disclose
 
Madeleine Trudy King
No Relationships to Disclose